Global Long Acting Insulins Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 309940
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Long Acting Insulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Long Acting Insulins market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Home Use accounting for % of the Long Acting Insulins global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Insulin Glargine segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Long Acting Insulins include Novo Nordisk, Sanofi, Wockhardt UK, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Long Acting Insulins market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Insulin Glargine

Insulin Determir

Insulin Degludec

Long Acting Animal Insulin

Market segment by Application, can be divided into

Home Use

Medical Institutions

Others

Market segment by players, this report covers

Novo Nordisk

Sanofi

Wockhardt UK

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Long Acting Insulins product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Long Acting Insulins, with revenue, gross margin and global market share of Long Acting Insulins from 2019 to 2022.

Chapter 3, the Long Acting Insulins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Long Acting Insulins market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Long Acting Insulins research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Long Acting Insulins

1.2 Classification of Long Acting Insulins by Type

1.2.1 Overview: Global Long Acting Insulins Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Long Acting Insulins Revenue Market Share by Type in 2021

1.2.3 Insulin Glargine

1.2.4 Insulin Determir

1.2.5 Insulin Degludec

1.2.6 Long Acting Animal Insulin

1.3 Global Long Acting Insulins Market by Application

1.3.1 Overview: Global Long Acting Insulins Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Home Use

1.3.3 Medical Institutions

1.3.4 Others

1.4 Global Long Acting Insulins Market Size & Forecast

1.5 Global Long Acting Insulins Market Size and Forecast by Region

1.5.1 Global Long Acting Insulins Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Long Acting Insulins Market Size by Region, (2017-2022)

1.5.3 North America Long Acting Insulins Market Size and Prospect (2017-2028)

1.5.4 Europe Long Acting Insulins Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Long Acting Insulins Market Size and Prospect (2017-2028)

1.5.6 South America Long Acting Insulins Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Long Acting Insulins Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Long Acting Insulins Market Drivers

1.6.2 Long Acting Insulins Market Restraints

1.6.3 Long Acting Insulins Trends Analysis

2 Company Profiles

2.1 Novo Nordisk

2.1.1 Novo Nordisk Details

2.1.2 Novo Nordisk Major Business

2.1.3 Novo Nordisk Long Acting Insulins Product and Solutions

2.1.4 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Novo Nordisk Recent Developments and Future Plans

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business

2.2.3 Sanofi Long Acting Insulins Product and Solutions

2.2.4 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Sanofi Recent Developments and Future Plans

2.3 Wockhardt UK

2.3.1 Wockhardt UK Details

2.3.2 Wockhardt UK Major Business

2.3.3 Wockhardt UK Long Acting Insulins Product and Solutions

2.3.4 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Wockhardt UK Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Long Acting Insulins Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Long Acting Insulins Players Market Share in 2021

3.2.2 Top 10 Long Acting Insulins Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Long Acting Insulins Players Head Office, Products and Services Provided

3.4 Long Acting Insulins Mergers & Acquisitions

3.5 Long Acting Insulins New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Long Acting Insulins Revenue and Market Share by Type (2017-2022)

4.2 Global Long Acting Insulins Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Long Acting Insulins Revenue Market Share by Application (2017-2022)

5.2 Global Long Acting Insulins Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Long Acting Insulins Revenue by Type (2017-2028)

6.2 North America Long Acting Insulins Revenue by Application (2017-2028)

6.3 North America Long Acting Insulins Market Size by Country

6.3.1 North America Long Acting Insulins Revenue by Country (2017-2028)

6.3.2 United States Long Acting Insulins Market Size and Forecast (2017-2028)

6.3.3 Canada Long Acting Insulins Market Size and Forecast (2017-2028)

6.3.4 Mexico Long Acting Insulins Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Long Acting Insulins Revenue by Type (2017-2028)

7.2 Europe Long Acting Insulins Revenue by Application (2017-2028)

7.3 Europe Long Acting Insulins Market Size by Country

7.3.1 Europe Long Acting Insulins Revenue by Country (2017-2028)

7.3.2 Germany Long Acting Insulins Market Size and Forecast (2017-2028)

7.3.3 France Long Acting Insulins Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Long Acting Insulins Market Size and Forecast (2017-2028)

7.3.5 Russia Long Acting Insulins Market Size and Forecast (2017-2028)

7.3.6 Italy Long Acting Insulins Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Long Acting Insulins Revenue by Type (2017-2028)

8.2 Asia-Pacific Long Acting Insulins Revenue by Application (2017-2028)

8.3 Asia-Pacific Long Acting Insulins Market Size by Region

8.3.1 Asia-Pacific Long Acting Insulins Revenue by Region (2017-2028)

8.3.2 China Long Acting Insulins Market Size and Forecast (2017-2028)

8.3.3 Japan Long Acting Insulins Market Size and Forecast (2017-2028)

8.3.4 South Korea Long Acting Insulins Market Size and Forecast (2017-2028)

8.3.5 India Long Acting Insulins Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Long Acting Insulins Market Size and Forecast (2017-2028)

8.3.7 Australia Long Acting Insulins Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Long Acting Insulins Revenue by Type (2017-2028)

9.2 South America Long Acting Insulins Revenue by Application (2017-2028)

9.3 South America Long Acting Insulins Market Size by Country

9.3.1 South America Long Acting Insulins Revenue by Country (2017-2028)

9.3.2 Brazil Long Acting Insulins Market Size and Forecast (2017-2028)

9.3.3 Argentina Long Acting Insulins Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Long Acting Insulins Revenue by Type (2017-2028)

10.2 Middle East & Africa Long Acting Insulins Revenue by Application (2017-2028)

10.3 Middle East & Africa Long Acting Insulins Market Size by Country

10.3.1 Middle East & Africa Long Acting Insulins Revenue by Country (2017-2028)

10.3.2 Turkey Long Acting Insulins Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Long Acting Insulins Market Size and Forecast (2017-2028)

10.3.4 UAE Long Acting Insulins Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Long Acting Insulins Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Long Acting Insulins Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Long Acting Insulins Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Long Acting Insulins Revenue (USD Million) by Region (2017-2022)

Table 5. Global Long Acting Insulins Revenue Market Share by Region (2023-2028)

Table 6. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 7. Novo Nordisk Major Business

Table 8. Novo Nordisk Long Acting Insulins Product and Solutions

Table 9. Novo Nordisk Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Sanofi Corporate Information, Head Office, and Major Competitors

Table 11. Sanofi Major Business

Table 12. Sanofi Long Acting Insulins Product and Solutions

Table 13. Sanofi Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Wockhardt UK Corporate Information, Head Office, and Major Competitors

Table 15. Wockhardt UK Major Business

Table 16. Wockhardt UK Long Acting Insulins Product and Solutions

Table 17. Wockhardt UK Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Global Long Acting Insulins Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 19. Global Long Acting Insulins Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 20. Breakdown of Long Acting Insulins by Company Type (Tier 1, Tier 2 and Tier 3)

Table 21. Long Acting Insulins Players Head Office, Products and Services Provided

Table 22. Long Acting Insulins Mergers & Acquisitions in the Past Five Years

Table 23. Long Acting Insulins New Entrants and Expansion Plans

Table 24. Global Long Acting Insulins Revenue (USD Million) by Type (2017-2022)

Table 25. Global Long Acting Insulins Revenue Share by Type (2017-2022)

Table 26. Global Long Acting Insulins Revenue Forecast by Type (2023-2028)

Table 27. Global Long Acting Insulins Revenue by Application (2017-2022)

Table 28. Global Long Acting Insulins Revenue Forecast by Application (2023-2028)

Table 29. North America Long Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 30. North America Long Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 31. North America Long Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 32. North America Long Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 33. North America Long Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 34. North America Long Acting Insulins Revenue by Country (2023-2028) & (USD Million)

Table 35. Europe Long Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 36. Europe Long Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 37. Europe Long Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 38. Europe Long Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 39. Europe Long Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 40. Europe Long Acting Insulins Revenue by Country (2023-2028) & (USD Million)

Table 41. Asia-Pacific Long Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 42. Asia-Pacific Long Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 43. Asia-Pacific Long Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 44. Asia-Pacific Long Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 45. Asia-Pacific Long Acting Insulins Revenue by Region (2017-2022) & (USD Million)

Table 46. Asia-Pacific Long Acting Insulins Revenue by Region (2023-2028) & (USD Million)

Table 47. South America Long Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 48. South America Long Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 49. South America Long Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 50. South America Long Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 51. South America Long Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 52. South America Long Acting Insulins Revenue by Country (2023-2028) & (USD Million)

Table 53. Middle East & Africa Long Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 54. Middle East & Africa Long Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 55. Middle East & Africa Long Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 56. Middle East & Africa Long Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 57. Middle East & Africa Long Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 58. Middle East & Africa Long Acting Insulins Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Long Acting Insulins Picture

Figure 2. Global Long Acting Insulins Revenue Market Share by Type in 2021

Figure 3. Insulin Glargine

Figure 4. Insulin Determir

Figure 5. Insulin Degludec

Figure 6. Long Acting Animal Insulin

Figure 7. Long Acting Insulins Revenue Market Share by Application in 2021

Figure 8. Home Use Picture

Figure 9. Medical Institutions Picture

Figure 10. Others Picture

Figure 11. Global Long Acting Insulins Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Long Acting Insulins Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Long Acting Insulins Revenue Market Share by Region (2017-2028)

Figure 14. Global Long Acting Insulins Revenue Market Share by Region in 2021

Figure 15. North America Long Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Long Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Long Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Long Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Long Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Long Acting Insulins Market Drivers

Figure 21. Long Acting Insulins Market Restraints

Figure 22. Long Acting Insulins Market Trends

Figure 23. Novo Nordisk Recent Developments and Future Plans

Figure 24. Sanofi Recent Developments and Future Plans

Figure 25. Wockhardt UK Recent Developments and Future Plans

Figure 26. Global Long Acting Insulins Revenue Share by Players in 2021

Figure 27. Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 28. Global Top 3 Players Long Acting Insulins Revenue Market Share in 2021

Figure 29. Global Top 10 Players Long Acting Insulins Revenue Market Share in 2021

Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 31. Global Long Acting Insulins Revenue Share by Type in 2021

Figure 32. Global Long Acting Insulins Market Share Forecast by Type (2023-2028)

Figure 33. Global Long Acting Insulins Revenue Share by Application in 2021

Figure 34. Global Long Acting Insulins Market Share Forecast by Application (2023-2028)

Figure 35. North America Long Acting Insulins Sales Market Share by Type (2017-2028)

Figure 36. North America Long Acting Insulins Sales Market Share by Application (2017-2028)

Figure 37. North America Long Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 38. United States Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 39. Canada Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Mexico Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Europe Long Acting Insulins Sales Market Share by Type (2017-2028)

Figure 42. Europe Long Acting Insulins Sales Market Share by Application (2017-2028)

Figure 43. Europe Long Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 44. Germany Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. France Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. United Kingdom Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Russia Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Italy Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Asia-Pacific Long Acting Insulins Sales Market Share by Type (2017-2028)

Figure 50. Asia-Pacific Long Acting Insulins Sales Market Share by Application (2017-2028)

Figure 51. Asia-Pacific Long Acting Insulins Revenue Market Share by Region (2017-2028)

Figure 52. China Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Japan Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. South Korea Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. India Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Southeast Asia Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Australia Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. South America Long Acting Insulins Sales Market Share by Type (2017-2028)

Figure 59. South America Long Acting Insulins Sales Market Share by Application (2017-2028)

Figure 60. South America Long Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 61. Brazil Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Argentina Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Middle East and Africa Long Acting Insulins Sales Market Share by Type (2017-2028)

Figure 64. Middle East and Africa Long Acting Insulins Sales Market Share by Application (2017-2028)

Figure 65. Middle East and Africa Long Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 66. Turkey Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Saudi Arabia Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. UAE Long Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Methodology

Figure 70. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz